Steward Partners Investment Advisory’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.9K | Buy |
13,840
+2,500
| +22% | +$6.13K | ﹤0.01% | 2670 |
|
|
2025
Q1 | $75.6K | Buy |
11,340
+4,640
| +69% | +$30.9K | ﹤0.01% | 2180 |
|
|
2024
Q4 | $84.2K | Sell |
6,700
-1,800
| -21% | -$22.6K | ﹤0.01% | 2066 |
|
|
2024
Q3 | $157K | Buy |
8,500
+1,000
| +13% | +$18.5K | ﹤0.01% | 1648 |
|
|
2024
Q2 | $161K | Hold |
7,500
| – | – | ﹤0.01% | 1547 |
|
|
2024
Q1 | $202K | Buy |
7,500
+2,500
| +50% | +$67.4K | ﹤0.01% | 1429 |
|
|
2023
Q4 | $150K | Hold |
5,000
| – | – | ﹤0.01% | 1498 |
|
|
2023
Q3 | $102K | Buy |
5,000
+500
| +11% | +$10.2K | ﹤0.01% | 1555 |
|
|
2023
Q2 | $89.4K | Hold |
4,500
| – | – | ﹤0.01% | 1631 |
|
|
2023
Q1 | $77.1K | Buy |
4,500
+2,500
| +125% | +$42.8K | ﹤0.01% | 1688 |
|
|
2022
Q4 | $39.1K | Buy |
+2,000
| New | +$39.1K | ﹤0.01% | 1940 |
|